L-Lysine Ameliorates Diabetic Nephropathy in Rats with Streptozotocin-Induced Diabetes Mellitus

Faezeh Jozi1, Nejat Kheiripour2, Maryam Akhavan Taheri3

  • 1Department of Clinical Biochemistry, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Abstract

Insights

L-lysine supplementation may slow diabetic nephropathy progression by improving blood glucose, reducing advanced glycation end-products, and enhancing antioxidant capacity in diabetic rats.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic nephropathy is a major cause of end-stage renal disease globally.
  • Uncontrolled hyperglycemia and glycation end-products drive diabetic nephropathy pathogenesis.
  • L-lysine's potential renoprotective effects warrant investigation.

Purpose of the Study:

  • To evaluate L-lysine's impact on antioxidant capacity, kidney function, and gene expression in diabetic rats.
  • To assess L-lysine's effects on biochemical markers and histology in streptozotocin-induced diabetic nephropathy.

Main Methods:

  • Thirty-two male Wistar rats were divided into four groups: healthy, diabetic+vehicle, diabetic+L-lysine, and healthy+L-lysine.
  • L-lysine (0.15%) was administered to relevant groups for eight weeks.
  • Key parameters measured included blood glucose, insulin, HbA1C, AGEs, lipid profile, kidney function markers, oxidative stress, HSP70, and gene expression (TGFβ, VEGF, RAGE).

Main Results:

  • L-lysine treatment significantly reduced fasting blood glucose, AGEs, kidney dysfunction markers, and oxidative stress.
  • Lipid profiles and gene expression of TGFβ, VEGF, and RAGE were significantly decreased by L-lysine.
  • Serum insulin and tissue HSP70 levels were significantly elevated following L-lysine administration.

Conclusions:

  • L-lysine supplementation demonstrates potential in mitigating diabetic nephropathy progression.
  • L-lysine may offer therapeutic benefits by improving metabolic control and reducing key pathological pathways in diabetic nephropathy.